Research use only (RUO)

Research Use Only, abbreviated RUO, is a regulatory label that a supplier applies to a product to indicate that it is intended for laboratory research and is not a drug, device, diagnostic, or food. An RUO product has not been reviewed for safety or efficacy for any use in people or animals; it has not been manufactured under the current Good Manufacturing Practice (cGMP) framework that applies to drug products; and it carries no claim of clinical utility. The category exists so that scientific materials - reference peptides, antibodies, cell lines, assay reagents - can move through the research economy without each of them being regulated as a medicine.

What RUO means in US regulation

The RUO category is defined by the US Food and Drug Administration in guidance that addresses how in vitro diagnostic products labeled for research use or investigational use should be distributed and labeled. See FDA Guidance: Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only (2013). While that guidance is specifically about in vitro diagnostics, the underlying principle - that labeling a material RUO is a statement about intended use and a disclaimer of clinical claims, not a quality grade - applies broadly across research materials. An RUO label does not exempt a supplier from truthful advertising obligations: representations about purity, identity, and composition still need to be accurate, and suppliers that in practice market RUO materials for human or veterinary administration can draw regulatory attention.

What RUO does not mean

RUO is not a synonym for "low quality." Many RUO reference peptides are produced in well-controlled synthesis facilities and characterized at a level comparable to pharmaceutical reference standards. What RUO does mean is that the quality system around the material is not the cGMP system required for medicines, that the identity and purity claims on the COA are the supplier's responsibility rather than having been reviewed by a regulator, and that the material has no approved clinical application. An accessible regulatory overview is Genzen et al., Clin. Chem. 2018 (NLM 29483112), which discusses RUO/IUO labeling in the laboratory context.

How Open Assay treats RUO listings

Every research peptide indexed on Open Assay is described on RUO terms. Listings describe the chemistry of the molecule - sequence, modifications, salt form, purity, endotoxin - and cite published research in which the molecule appears. Listings do not contain instructions for human or veterinary use, do not compare research materials to approved medicines as if they were therapeutically interchangeable, and do not use clinical vocabulary such as "patients," "dose," or "treatment." This editorial constraint is documented at openassay.org/editorial-policy and is a condition of listing.